83 related articles for article (PubMed ID: 19682066)
1. Intra-atrial thrombosis complicating myocardial relapse of leukaemia.
Kamel S; Ritchie D
Eur J Haematol; 2010 Feb; 84(2):187. PubMed ID: 19682066
[No Abstract] [Full Text] [Related]
2. Postallogeneic hematopoietic stem cell transplantation relapse of acute myeloid leukemia presenting with salivary gland myelosarcoma.
Lai YH; Chang CS; Liu YC; Liu TC
Ann Hematol; 2010 Jun; 89(6):631-3. PubMed ID: 19816683
[No Abstract] [Full Text] [Related]
3. Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation.
Au WY; Lie AK; Lee CK; Liang R; Kwong YL
Bone Marrow Transplant; 1999 Jun; 23(11):1201-3. PubMed ID: 10382962
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
5. Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state aml after allogeneic stem cell transplantation.
Hartwig M; Weigel S; Bernig T; Bader P; Dölken R; Beck J
Pediatr Hematol Oncol; 2007 Mar; 24(2):137-40. PubMed ID: 17454780
[TBL] [Abstract][Full Text] [Related]
6. Cerebral tuberculosis post stem cell transplant.
Bloor AJ; Mackinnon S
Eur J Haematol; 2006 Nov; 77(5):456. PubMed ID: 16856918
[No Abstract] [Full Text] [Related]
7. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
Schmid C; Schleuning M; Ledderose G; Tischer J; Kolb HJ
J Clin Oncol; 2005 Aug; 23(24):5675-87. PubMed ID: 16110027
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcoma.
Waselewski A; Joiner M; Miller SR
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30389743
[TBL] [Abstract][Full Text] [Related]
9. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.
Pérez A; González-Vicent M; Ramirez M; Sevilla J; Madero L; Díaz MA
Br J Haematol; 2008 Feb; 140(3):340-3. PubMed ID: 18053071
[TBL] [Abstract][Full Text] [Related]
10. Extramedullary relapse in the so-called 'sanctuary' sites for chemotherapy after donor lymphocyte infusion.
Seo S; Kami M; Honda H; Kashima T; Matsumura T; Moriya A; Machida U; Kanda Y; Chiba S; Hirai H
Bone Marrow Transplant; 2000 Jan; 25(2):226-7. PubMed ID: 10673689
[No Abstract] [Full Text] [Related]
11. [Myocardial infiltration and formation of multiple granulocytic sarcoma of acute myeloid leukemia after cord blood transplantation].
Hagihara M; Motohashi K; Ohshima R; Ito S; Sakuma Y; Kameda Y; Maruta A; Ishigatsubo Y; Kanamori H
Rinsho Ketsueki; 2009 Jul; 50(7):574-6. PubMed ID: 19638726
[TBL] [Abstract][Full Text] [Related]
12. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
[TBL] [Abstract][Full Text] [Related]
13. Donor lymphocyte infusions for acute myeloid leukaemia.
Soiffer RJ
Best Pract Res Clin Haematol; 2008 Sep; 21(3):455-66. PubMed ID: 18790449
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality.
Meijer E; Cornelissen JJ
Semin Oncol; 2008 Aug; 35(4):449-57. PubMed ID: 18692695
[TBL] [Abstract][Full Text] [Related]
15. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
[TBL] [Abstract][Full Text] [Related]
16. Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation.
Gómez M; Urbano-Ispizua A; Cervantes F; Fernández-Avilés F; Rovira M; Carreras E
Haematologica; 2002 Sep; 87(9):1003-5. PubMed ID: 12217814
[TBL] [Abstract][Full Text] [Related]
17. Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion.
Gesundheit B; Shapira MY; Maly A; Samuel S; Budowski E; Or R
Leuk Res; 2008 Mar; 32(3):501-3. PubMed ID: 17727947
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
de Labarthe A; Pautas C; Thomas X; de Botton S; Bordessoule D; Tilly H; de Revel T; Bastard C; Preudhomme C; Michallet M; Fenaux P; Bastie JN; Socié G; Cordonnier C; Dombret H;
Bone Marrow Transplant; 2005 Apr; 35(8):767-73. PubMed ID: 15735660
[TBL] [Abstract][Full Text] [Related]
19. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
20. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
Schmid C; Labopin M; Nagler A; Bornhäuser M; Finke J; Fassas A; Volin L; Gürman G; Maertens J; Bordigoni P; Holler E; Ehninger G; Polge E; Gorin NC; Kolb HJ; Rocha V;
J Clin Oncol; 2007 Nov; 25(31):4938-45. PubMed ID: 17909197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
